New Horizon Health Ltd. is a biotechnology company focused on the development and commercialization of early cancer screening products. As a pioneering entity in non-invasive cancer detection, the com... New Horizon Health Ltd. is a biotechnology company focused on the development and commercialization of early cancer screening products. As a pioneering entity in non-invasive cancer detection, the company utilizes its advanced molecular diagnostic technologies to create effective and accessible testing solutions. New Horizon Health focuses particularly on colorectal and other high-incidence cancers, aiming to address crucial needs in preventative healthcare. Through its innovative approach, the company plays a pivotal role in the healthcare and biotechnology sectors by transforming early cancer detection processes, thus facilitating early intervention and treatment strategies. New Horizon Health Ltd. markets its products primarily in China but is expanding its reach to international markets, thereby influencing global public health paradigms. By providing reliable, early-stage cancer screening tools, the company not only enhances patient outcomes but also supports a shift towards personalized medical care in modern healthcare systems.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

New Horizon Health is not subject to EU Taxonomy reporting

Based on current regulatory requirements, New Horizon Health is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review New Horizon Health's data?

Start your 30-day free trial to request a data review for New Horizon Health.

Start Free Trial

Legal Center Contact Us